| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (10MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-751824
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.75182
Zusammenfassung
Background About 655 million persons worldwide are affected by osteoarthritis (OA). As no therapy modifies disease progression long-term, there is an immense clinical need for novel therapies. The joints are innervated by alpha calcitonin gene-related peptide (αCGRP)- and substance P (SP)-positive sensory nerve fibers. Both neuropeptides have trophic effects on target cells within the joints. ...

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

Downloadstatistik